Roche Seen Offering NICE Further Price Cut For MS Drug Ocrevus

MS
NICE Says Roche’s Offered Price For MS Drug Ocrevus Still Too High • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip